Dr. Charles Michael Fischman, MD

Dr. Fischman practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida.

Dr. Fischman's NPI, 1255314365, was assigned on November 22, 2005. Dr. Fischman graduated from Tulane School of Medicine in 1974. Dr. Fischman holds Florida license ME25700.

Dr. Fischman's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Fischman's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida. The medical group on file is Indian River Primary Care. Dmand AI also links Dr. Fischman to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fischman practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Fischman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Fischman is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Fischman's licenses on file in 6 states: Florida, Arizona, California, Georgia, Louisiana and Texas.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, alcohol use disorders, alzheimer's disease, aneurysm and ankle or foot injury among the conditions Dr. Fischman treats.

CMS data shows 117 Medicare services from Dr. Fischman across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $9,606 for them. Every service was in an office.

CMS counts 68 Medicare patients who saw Dr. Fischman in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fischman's median patient age at 81, with 63% women.

In 2024, Dr. Fischman wrote 399 Medicare Part D claims for 179 patients. 71% of them were for generic drugs. CMS names the drug for 179 of them, across 9 drugs with 11 or more claims each, at $34,868 in total drug cost. In 2023, CMS named 4,104 claims across 72 drugs.

Dmand AI links 7 papers to Dr. Fischman. The most frequent topics are Cyclohexanones, Glutathione and Cells, Cultured. Dr. Fischman has published most often in J Clin Invest. Dr. Fischman's most frequent co-author is Laurence Bernard Gardner, MD.

CMS Open Payments shows 26 general payments to Dr. Fischman from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $263.

Dr. Fischman graduated from Tulane School of Medicine in 1974.

Dr. Fischman is in network with 9 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.